Go back
“ We founded ARCHIMED in 2014, with the belief that setting up a specialized fund dedicated to healthcare would make a positive difference for both businesses, investors, and ultimately for the people and patients around the world. Our team is striving every day to bring new treatment and better healthcare to patients around the world.”
Denis Ribon is the Chairman of ARCHIMED. He is also a Managing Partner and a member of Life Science Tools & Biologics Services sector team. Denis is also a Director of the EURÊKA Foundation, ARCHIMED’s charitable foundation. He has a long-standing relationship with other ARCHIMED partners, dating back over 20 years.
Denis has over 30 years of experience in the healthcare sector.
Denis started his career as a veterinarian and subsequently worked for management consulting firm A.T. Kearney. In 2001, Denis joined a private equity firm, 3i, and became the global head of the healthcare team in 2007, overseeing the company’s healthcare investments and portfolio across Europe, North America, and Asia.
Denis actively contributed to the development and strategic growth of companies in various healthcare sectors. He has served as a Deal Partner, Board Chairman or Board Director in more than 30 public and private healthcare companies, including ActiGraph, Aliri, Biodextris, Cair LGL, CARSO, Citieffe, Clean Cells, Corealis, Cube, Deallus, Fytexia, Labco (now Synlab), Micromed, NAMSA, Natus, Neftys Pharma, Polyplus, Prollenium, Provepharm, Quintiles (now Iqvia), Stragen, SUANFARMA, Vétoquinol, operating in all types of healthcare sub-sectors.
Denis is also a Director of the EURÊKA Foundation, ARCHIMED’s charitable foundation. He has a long-standing relationship with other ARCHIMED partners, for more than 20 years.
PORTFOLIO COMPANIES
